- 08:15 - 01/04/2025 to 09:00 - 01/04/2025
- Virtual event, United Kingdom
Join The Limbic, in partnership with the BSHT, for an in-depth discussion on the potential role of Von Willebrand Factor (VWF)-platelet interactions in determining survival outcomes for patients with intracerebral haemorrhage (ICH).
The College is delighted to have approved this external event for CPD credits.
If you have any questions regarding this event, please see host's information at the bottom of this page or via the Book Now button.
TOPICS COVERED
Dr. Mike Desborough and Dr. Alex Bye will explore in vitro research on the interplay between VWF and antiplatelet drugs, alongside an overview of desmopressin—a potential treatment for antiplatelet-associated ICH currently under investigation in the DASH-1 and DASH-2 trials.
WHO SHOULD ATTEND?
Consultant, trainee haematologists and neurologists.
SPEAKERS
- Dr Mike Desborough. Consultant Haematologist at Oxford University Hospitals NHS Foundation Trust and Associate Professor of Haematology at Oxford University.
- Dr Alex Bye. Lecturer in Pharmacology at the University of Reading.
